Webinar Date/Time: Wednesday, May 15th, 2024 at 10am EDT | 7am PDT | 3pm BST | 4pm CEST
Are you using the most appropriate data to understand the patient journey and improve your oncology clinical trial design? Register to learn how real-world data can provide more precise estimations of specific oncology patient sub-populations to yield shorter recruitment times and avoid costly amendments.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1663847&tp_key=a90a159aa5
Event Overview:
Traditional data sources can be incomplete and do not always adequately account for regional differences in prevalence of oncology sub-populations. This can lead to inaccurate estimations being used for clinical trial design, resulting in patient recruitment challenges and increased risk of costly amendments.
This webinar illustrates how real-world data (RWD) yields patient journey insights and more precise estimations of specific oncology patient sub-populations that can be used to optimize oncology clinical trial design and reap significant benefits.
Three Key Take-Aways:
Speakers:
Sergio Sánchez-Gambetta, MD
Design Analytics Director
IQVIA
Sergio Sánchez-Gambetta, based in Perú, South America, joined IQVIA in January 2023. In his role, he collaborates with other clinical trial experts to deliver analytic-based protocol assessment insights, helping sponsors make informed trial design strategy decisions.
Sergio is a MD and holds a master’s degree in Epidemiology (quantitative methods focus). He has >17 years’ experience across clinical research, real world data/evidence applications, study start up and medical affairs. He has held various roles at research centers, global CROs and Roche Pharmaceuticals.
Sergio has been teaching within the Clinical Research master’s and diploma programs at 3 Peruvian Universities since 2017. In 2020, he became an external member of a Local Ethics Committee, where he reviews Medical Device protocols and projects. Along with his peers, he participates in analysing data and contributing to medical publications.
Register Free: https://globalmeet.webcasts.com/starthere.jsp?ei=1663847&tp_key=a90a159aa5
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
April 22nd 2025With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics production, gene therapy capabilities, and next generation R&D centers.